AD, G., E, C., P, B., D, P., G, F., FD, V., . . . F, S. (2026). Vedolizumab for the prevention and treatment of postoperative recurrence in Crohn's disease: A real- world latium net study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 58(8), 1037. https://doi.org/10.1016/j.dld.2026.05.002
Chicago Style (17th ed.) CitationAD, Gaudio, et al. "Vedolizumab for the Prevention and Treatment of Postoperative Recurrence in Crohn's Disease: A Real- World Latium Net Study." Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 58, no. 8 (2026): 1037. https://doi.org/10.1016/j.dld.2026.05.002.
MLA (9th ed.) CitationAD, Gaudio, et al. "Vedolizumab for the Prevention and Treatment of Postoperative Recurrence in Crohn's Disease: A Real- World Latium Net Study." Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol. 58, no. 8, 2026, p. 1037, https://doi.org/10.1016/j.dld.2026.05.002.
